ExoStemTech
PrivateLast Round
Strategic
Dec 1, 2021
Est. Valuation
$71.4M
Total Funding Raised
$12.03M
Company Overview
ExoStemTech is a biotechnology company that develops exosome-based therapeutic systems for tissue repair and regeneration, focusing on conditions such as osteoarthritis, liver fibrosis, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExoStemTech Comparables
Compare ExoStemTech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BREXOGEN Inc. | 89% | |
| ILIAS Biologics Inc. | 87% | |
| EVerZom | 81% |
ExoStemTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 1, 2021 | ||||
| Series B | Oct 26, 2021 |
ExoStemTech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DSC Investment | Series B, Series A |
| Hana Securities | Series B |
| We Ventures | Series B |
| IMM Investment | Series B, Series A |
| Laguna Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2021
Daewoong Pharmaceutical participated in the round.
- Oct 26, 2021
$8.4M round led by DSC Investment.
ExoStemTech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ExoStemTech's valuation, stock price, and market status.
Is ExoStemTech a public or private company?
ExoStemTech is a private company.
What is the current stock price of ExoStemTech?
ExoStemTech is a private company with no public stock price. No recent secondary market data is available.
How much is ExoStemTech worth (valuation)?
ExoStemTech's valuation is estimated at $71.4M based on funding round data.
Can I buy ExoStemTech stock?
ExoStemTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ExoStemTech's last funding round?
ExoStemTech's most recent funding round was Strategic on October 26, 2021.
Who are the main investors in ExoStemTech?
Key investors in ExoStemTech include DSC Investment, Hana Securities, We Ventures, IMM Investment, Laguna Investment.
Will ExoStemTech IPO soon?
No public IPO plans have been announced for ExoStemTech.
How can I track ExoStemTech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ExoStemTech's secondary market activity and sign up for updates.